Value proposition

Medical Publishing Insights & Practices (MPIP) was founded by members of the pharmaceutical industry and the International Society for Medical Publication Professionals (ISMPP) to elevate trust, transparency, and integrity in publishing industry-sponsored research. Current corporate co-sponsors include Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Research & Development LLC, Merck, Pfizer, and Takeda.

Since our inception in 2008, MPIP has promoted more effective partnership between sponsors and journals to raise standards in medical publications and expand access to research results. Through independent research, industry ̶ journal roundtables, and multidisciplinary collaboration, MPIP works to enhance understanding of challenges in publishing industry-sponsored research and develop tangible solutions. Our research results are disseminated through publications, education, and outreach at society meetings, webcasts and webinars.

What Have We Accomplished?
------------------------------------------
MPIP has collaborated with editors of worldwide biomedical journals, publication professionals, academic researchers, and investigators on the following initiatives:

• Recommendations to Improve AE Reporting in Clinical Trial Publications: a Joint Pharmaceutical Industry/Journal Editor Perspective
• Transparency and Credibility of Industry-Sponsored Clinical Trial Publications: a Survey of Journal Editors
• 5-Step Authorship Framework to Improve Transparency in Disclosing Contributors to Industry-Sponsored Clinical Trial Publications
• Ten Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research
• Authors’ Submission Toolkit

More information on initiatives can be found at www.mpip-initiative.org.

Advocacy for transparency in reporting industry-sponsored clinical research in medical publications and facilitating dialogue between journal editors and Pharma